These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16423505)

  • 1. Measuring remission in schizophrenia: response to Sethuraman et al., 2005.
    Kujawa M; Bossie CA; Lasser RA
    Schizophr Res; 2006 Mar; 83(1):109-10. PubMed ID: 16423505
    [No Abstract]   [Full Text] [Related]  

  • 2. [The possibility of high-quality remission in the long chronic course of schizophrenia].
    Danilov DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):80-5. PubMed ID: 19140265
    [No Abstract]   [Full Text] [Related]  

  • 3. Great(er) expectations.
    Lauriello J
    Am J Psychiatry; 2007 Mar; 164(3):377-9. PubMed ID: 17329458
    [No Abstract]   [Full Text] [Related]  

  • 4. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
    Schennach-Wolff R; Möller HJ; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M
    Pharmacopsychiatry; 2010 Nov; 43(7):245-51. PubMed ID: 20927697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Schizophrenia].
    Finnish Psychiatrists' Association
    Duodecim; 2001; 117(24):2640-57. PubMed ID: 12183827
    [No Abstract]   [Full Text] [Related]  

  • 6. How to manage the first episode of schizophrenia.
    Frangou S; Byrne P
    BMJ; 2000 Sep; 321(7260):522-3. PubMed ID: 10968798
    [No Abstract]   [Full Text] [Related]  

  • 7. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
    Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
    Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive-compulsive symptoms in schizophrenia: their relationship with clinical features and pharmacological treatment.
    Nolfe G; Milano W; Zontini G; Petrella C; De Rosa M; Rundle-Smith S; Nolfe G
    J Psychiatr Pract; 2010 Jul; 16(4):235-42. PubMed ID: 20644358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.
    Valencia M; Fresan A; Juárez F; Escamilla R; Saracco R
    J Psychiatr Res; 2013 Dec; 47(12):1886-92. PubMed ID: 24112947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clozapine in the treatment of schizophrenia].
    Raitasuo V
    Duodecim; 2000; 116(11):1199-204; quiz 1205. PubMed ID: 11989005
    [No Abstract]   [Full Text] [Related]  

  • 11. Researchers focus on recovery in schizophrenia.
    Friedrich MJ
    JAMA; 2014 Jul; 312(1):16-8. PubMed ID: 24942273
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives on treatment needs in schizophrenia.
    Meise U; Fleischhacker WW
    Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
    [No Abstract]   [Full Text] [Related]  

  • 13. Concordance of patient and clinical ratings of symptom severity and change of psychotic illness.
    Rabinowitz J; Levine SZ; Medori R; Oosthuizen P; Koen L; Emsley R
    Schizophr Res; 2008 Mar; 100(1-3):359-60. PubMed ID: 18077138
    [No Abstract]   [Full Text] [Related]  

  • 14. Life satisfaction among individuals with schizophrenia in the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) study.
    Fervaha G; Agid O; Takeuchi H; Foussias G; Remington G
    Am J Psychiatry; 2013 Sep; 170(9):1061-2. PubMed ID: 24030617
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of clozapine-associated tardive dyskinesia.
    Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
    [No Abstract]   [Full Text] [Related]  

  • 16. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
    Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
    Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reply to comments on "Optimizing early prediction for antipsychotic response in schizophrenia".
    Chang YC; Lane HY
    J Clin Psychopharmacol; 2009 Aug; 29(4):391. PubMed ID: 19593183
    [No Abstract]   [Full Text] [Related]  

  • 18. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
    Wobrock T; Köhler J; Klein P; Falkai P
    Acta Psychiatr Scand; 2009 Aug; 120(2):120-8. PubMed ID: 19392812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
    Heinrichs RW
    Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of remission and recovery in schizophrenia in the Czech Republic.
    Prikryl R; Kholova M; Kucerova HP; Ceskova E
    Compr Psychiatry; 2013 Oct; 54(7):1111-6. PubMed ID: 23810077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.